Shirahata, A., Fukutake, K., Takamatsu, J., Shima, M., Hanabusa, H., Mugishima, H., Amano, K., Takedani, H., Tamashima, S., Matsushita, T., Tawa, A., Tanaka, I., Higasa, S., Kosaka, Y., Fujii, T., Sakai, M., Migita, M., Kawakami, K., Ohashi, Y., & Saito, H. (n.d.). a Phase II clinical trial of a mixture of plasma‐derived factor VIIa and factor X (MC710) in haemophilia patients with inhibitors: haemostatic efficacy, safety and pharmacokinetics/pharmacodynamics. Haemophilia, 19, 853–860. http://access.bl.uk/ark:/81055/vdc_100044393381.0x000001